Eloxx director exercises RSUs, granted stock options
Eloxx Pharmaceuticals director Steven D. Rubin reported routine equity compensation activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Eloxx Pharmaceuticals director Steven D. Rubin reported routine equity compensation activity. On January 24, 2026, he exercised 1,875 restricted stock units (RSUs), receiving an equal number of common shares at $0.00 per share, lifting his direct common stock holdings to 14,625 shares.
Following this RSU conversion, Rubin still held 1,875 RSUs. Earlier, on September 19, 2025, he received a grant of 179,854 stock options for common stock at a $0.15 exercise price, vesting 1/36 on October 31, 2025, then in equal monthly installments over 35 months until September 2035.
Insider Trade Summary
1,875 shares exercised/converted
Exercise
3 txns
Insider
Rubin Steven D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,875 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,875 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 179,854 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 179,854 contracts (Direct);
Restricted Stock Units — 1,875 contracts (Direct);
Common Stock — 14,625 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2. The stock option vested as to 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
- F3. The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter.
Key Figures
RSUs exercised: 1,875 shares
Common shares held: 14,625 shares
RSUs remaining: 1,875 units
+4 more
7 metrics
RSUs exercised
1,875 shares
Common stock received on January 24, 2026
Common shares held
14,625 shares
Direct holdings after January 24, 2026 transaction
RSUs remaining
1,875 units
Restricted Stock Units outstanding after conversion
Stock options granted
179,854 options
Grant on September 19, 2025 for common stock
Option exercise price
$0.15 per share
Conversion or exercise price for 179,854 options
Option expiration
September 19, 2035
Expiration date of 179,854 stock options
Initial option vesting fraction
1/36
First tranche vested on October 31, 2025
Key Terms
Restricted Stock Units, stock option, exercise price, vesting, +1 more
5 terms
Restricted Stock Units financial
"The RSUs vested as to 50% on the first anniversary of January 24, 2024"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"The stock option vested as to 1/36 on October 31, 2025"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "0.1500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"with the remaining options vesting thereafter in equal consecutive monthly increments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Eloxx (ELOX) director Steven D. Rubin report on this Form 4?
Director Steven D. Rubin reported equity compensation activity, not open-market trades. He exercised 1,875 restricted stock units into common shares and disclosed holdings of 14,625 common shares, 1,875 RSUs, and 179,854 stock options granted at a $0.15 exercise price.
What stock option grant did Steven D. Rubin receive from Eloxx (ELOX)?
Steven D. Rubin received a grant of 179,854 Eloxx stock options on September 19, 2025 at a $0.15 exercise price. The options vest 1/36 on October 31, 2025, with remaining options vesting monthly over 35 months, and expire on September 19, 2035.
How do the reported RSUs for Eloxx (ELOX) director Steven D. Rubin vest?
Each RSU represents a right to receive one Eloxx common share. The RSUs vested 50% on the first anniversary of January 24, 2024, with the remaining amount vesting in two equal annual installments thereafter, aligning equity compensation with continued service to the company.
Were Steven D. Rubin’s reported Eloxx (ELOX) transactions open-market buys or sells?
The reported transactions were not open-market buys or sells. They reflect an RSU conversion into 1,875 common shares and a previously granted stock option award, both forms of equity compensation rather than discretionary trading in Eloxx stock on the public market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates